AMERICANALMANAC (Sadie Smith) - Trump's FDA pick Heidi Overton faces confirmation fight as pro-life leaders eye mifepristone crackdown
President Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, could force a long-delayed reckoning over the safety of the abortion drug mifepristone, but she first faces resistance from both parties in the Senate. John Mize, CEO of Americans United for Life, told Fox News Digital that Overton would bring "objectivity" to […] The post Trump's FDA pick Heidi Overton faces confirmation fight as pro-life leaders eye mifepristone crackdown appeared first on American Almanac .
President Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, could force a long-delayed reckoning over the safety of the abortion drug mifepristone, but she first faces resistance from both parties in the Senate. John Mize, CEO of Americans United for Life, told Fox News Digital that Overton would bring "objectivity" to the FDA's handling of mifepristone, the chemical abortion drug that now accounts for roughly two-thirds of all clinician-provided abortions in the United States. Mize said he has spoken with Overton five or six times and believes she understands the risks the drug poses to women, particularly under the current rules that allow it to be prescribed after a telehealth visit and shipped by mail…Open